Poly(methylglyoxylate), a biodegradable polymeric material for new drug delivery systems

International Journal of Pharmaceutics

Volumn 169, Issue 1, 1998, Pages 23-31

  Brachais, C H ^a   Duclos, R ^b   Vaugelade, C ^a   Huguet, J ^a   Capelle Hue, M L ^b   Bunel, C ^a  

^a UNIVERSITÉ ET INSA DE ROUEN   (France)

^b UNIVERSITÉ DE ROUEN   (France)

Author keywords

Biodegradable matrix; Dissolution profiles; Metoprolol; Poly(methylglyoxylate); Solid dispersions

Indexed keywords

METOPROLOL; POLY(METHYLGLYOXYLATE); POLYMER; UNCLASSIFIED DRUG;

ARTICLE; BIODEGRADATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG SOLUBILITY; PRIORITY JOURNAL; SUSTAINED RELEASE PREPARATION;

EID: 0032581239     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(98)00100-8     Document Type: Article

References (16)

1. Benfield, P., Clissold, S.P., Brogdern, R.N., 1986. Metoprolol: an update review of its pharmacodynamic and pharmacokinetic and therapeutic efficacy in hypertension, ischaemic heart disease and related cadiovascular disorders. ADIS Drug Information Services. Auckland: ADIS Press Limited.
2. Block, D.W., Speiser, P.P., 1987. Solid dispersions - Fundamentals and examples. Pharm. Acta Helv. 62 (1), 23-27.
3. Brachais, C.-H., Duclos, R., Capelle-Hue, M.-L., Van Dessel-Biere, C., Huguet, J., Orecchioni, A.-M., Bunel, C., 1994. Poly(methylglyoxylate), a new potentially biodegradable polymeric material for drug release: synthesis and physicochemical properties. Proc. Int. Symp. Control. Release Bioact. Mater. 21, 636.
4. Brachais, C.-H., Huguet, J., Bunel, C., 1997. Synthesis, characterisation and stabilisation of poly(methylglyoxylate). Polymer 38 (19), 4959-4964.
5. Brachais, C.-H., Brachais, L., Huguet, J., Bunel, C., 1998. In vitro degradation of poly(methylglyoxylate) in water. Polymer 39, 4883-4890.
6. Brachais, C.-H., Brachais, L., Huguet, J., Bunel, C., Identification of small molecules issued from PMG in vitro degradation. Polymer. Submitted (1998).
7. Chiou, W.L., 1971. Riegelman's Pharmaceutical application of solid dispersion systems. J. Pharm. Sci. 60 (9), 1281-1302.
8. Duchene, D., 1986. Les dispersions solides: interêts et limites. In: Fabre, P. (Ed.), Les entretiens du Carla, Tome VII, pp. 99-107.
9. Duclos, R., Brachais, C.-H., Capelle-Hue, M.-L., Van Dessel-Biere, C., Huguet, J., Orecchioni, A.-M., Bunel, C., 1994. Pharmaceutical properties of poly(methylglyoxylate) as matrix for drug release. Proc. 13th Pharm. Techn. Conf. 1a, 419.
10. Duclos, R., Brachais, C.-H., Orecchioni, A.-M. and Bunel, C., 1995. Biopharmaceutical studies of poly(methylglyoxylate) as potential drug carrier. Proc. 1st Int. Conf. Pharm. Tech. 477-478.
11. Ford, J.L., 1987. The current status of solid dispersions. Pharm. Acta Helv. 62 (1), 23-27.
12. Muller, E., 1992. Thesis. Université Pierre et Marie Curie, Paris VI.
13. Robinson, D.H., Sampath, S.S., 1989. Release kinetics of tobramycin sulfate from polymethylmethacrylate implants. Drug Dev. Ind. Pharm. 15, 2339-2357.
14. Vairon, J.P., Muller, E., Bunel, C., 1994a. Makromol. Chem. Macromol. Symp. 85, 307.
15. Vairon, J.P., Muller, E., Bunel, C., 1994b. J. Macromol. Sci. Macromol. Rep. A31 (6/7), 821.
16. Weston, M., Sampath, S., Robinson, D., Garvin, K., 1991. Comparative in vitro release of antibiotics from non-biodegradable and biodegradable implants for osteomyelitis. 37th Annual Meeting of the Orthopedic Research Society, Anaheim, CA, March 4-7.